LA
Lifeworks Advisors Portfolio holdings
AUM
$671M
This Quarter Return
-3.22%
1 Year Return
+13.63%
3 Year Return
+53.28%
5 Year Return
–
10 Year Return
–
AUM
$256M
AUM Growth
+$256M
(+9.2%)
Cap. Flow
+$29.3M
Cap. Flow
% of AUM
11.45%
Top 10 Holdings %
Top 10 Hldgs %
24.23%
Holding
192
New
37
Increased
80
Reduced
59
Closed
11
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$2.91M |
| 2 |
SPDR Portfolio Developed World ex-US ETF
SPDW
|
$2.32M |
| 3 |
Amazon
AMZN
|
$2.15M |
| 4 |
Moderna
MRNA
|
$1.74M |
| 5 |
SPDR Portfolio S&P 500 ETF
SPLG
|
$1.6M |
Top Sells
| 1 |
Intel
INTC
|
$1.8M |
| 2 |
Celanese
CE
|
$1.11M |
| 3 |
Micron Technology
MU
|
$1.09M |
| 4 |
Eli Lilly
LLY
|
$1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$870K |
Sector Composition
| 1 | Healthcare | 18.64% |
| 2 | Technology | 17.33% |
| 3 | Industrials | 7.05% |
| 4 | Consumer Staples | 5.65% |
| 5 | Consumer Discretionary | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$15.7B
| $8.09M | 3.15% | 171,078 +14,437 | +9% | +$683K |
|
2
iShares US Treasury Bond ETF
GOVT
$27.9B
| $7.87M | 3.06% | 357,250 +55,369 | +18% | +$1.22M |
|
3
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.5B
| $6.5M | 2.53% | 63,743 +9,879 | +18% | +$1.01M |
|
4
Fidelity MSCI Health Care Index ETF
FHLC
$2.46B
| $6.45M | 2.51% | 106,483 +567 | +0.5% | +$34.3K |
|
5
VanEck Merk Gold Trust
OUNZ
$1.85B
| $6.08M | 2.37% | 340,072 -7,952 | -2% | -$142K |
|
6
Fidelity MSCI Information Technology Index ETF
FTEC
$15.1B
| $6.01M | 2.34% | 48,879 -2,552 | -5% | -$314K |
|
7
Vanguard Total International Bond ETF
BNDX
$68.3B
| $5.59M | 2.17% | 116,807 +15,699 | +16% | +$751K |
|
8
Johnson & Johnson
JNJ
$427B
| $5.18M | 2.01% | 33,240 -2,011 | -6% | -$313K |
|
9
Apple
AAPL
$3.45T
| $5.17M | 2.01% | 30,209 -2,033 | -6% | -$348K |
|
10
iShares MBS ETF
MBB
$41B
| $5.16M | 2.01% | 58,055 +8,714 | +18% | +$774K |
|
11
Campbell Soup
CPB
$9.52B
| $4.41M | 1.72% | 107,388 +11,474 | +12% | +$471K |
|
|
12
Eli Lilly
LLY
$657B
| $4.37M | 1.7% | 8,135 -1,866 | -19% | -$1M |
|
13
Gilead Sciences
GILD
$140B
| $4.24M | 1.65% | 56,565 +3,464 | +7% | +$260K |
|
14
Amgen
AMGN
$155B
| $4.18M | 1.63% | 15,562 +1,279 | +9% | +$344K |
|
15
Merck
MRK
$210B
| $4.15M | 1.62% | 40,328 +2,200 | +6% | +$226K |
|
16
Otis Worldwide
OTIS
$33.9B
| $3.88M | 1.51% | 48,312 -1,682 | -3% | -$135K |
|
17
Cisco
CSCO
$274B
| $3.84M | 1.49% | 71,355 +1,142 | +2% | +$61.4K |
|
18
Pfizer
PFE
$141B
| $3.82M | 1.48% | 115,039 +15,624 | +16% | +$518K |
|
19
AbbVie
ABBV
$372B
| $3.76M | 1.46% | 25,231 +940 | +4% | +$140K |
|
20
Regeneron Pharmaceuticals
REGN
$61.5B
| $3.72M | 1.45% | 4,516 +243 | +6% | +$200K |
|
|
21
SPDR Portfolio Developed World ex-US ETF
SPDW
$29.1B
| $3.71M | 1.44% | 119,610 +74,704 | +166% | +$2.32M |
|
22
Oracle
ORCL
$635B
| $3.61M | 1.4% | 34,089 -5,849 | -15% | -$620K |
|
23
Microsoft
MSFT
$3.77T
| $3.55M | 1.38% | 11,250 -1,717 | -13% | -$542K |
|
24
Biogen
BIIB
$19.4B
| $3.22M | 1.25% | 12,522 +2,605 | +26% | +$669K |
|
25
PACCAR
PCAR
$52.5B
| $3.08M | 1.2% | 36,220 +2,473 | +7% | +$210K |
|